Facial erythema, or redness may be managed with the use of topical vasoconstrictors such as brimonidine or oxymetazoline.3 Currently, oxymetazoline and brimonidine are the only two active pharmaceutical ingredients (APIs) approved for the management of persistent facial erythema associated with rosacea.4 Though rosacea manifests in a variety of ways, erythema is a major concern for many patients suffering from rosacea
Mackensen, A
The occurrence of secondary brain injuries (SBI) following TBI significantly exacerbates the pathophysiological processes involved, leading to poor neurological outcomes [4,5,6]
Reduces sunburn, photoaging, and melasma
Butera A, De Simone R, Potenza RL, Sanchez M, Armida M, Campanile D, Di Carlo N, Trenta F, Boirivant M, Ricceri L
We are an expert biotechnology company that provides high quality peptides and products for purchase to advance scientific research in this field.